PUBLISHER: TechNavio | PRODUCT CODE: 1911223
PUBLISHER: TechNavio | PRODUCT CODE: 1911223
The global microrna (mirna) market is forecasted to grow by USD 4211.4 mn during 2025-2030, accelerating at a CAGR of 22.3% during the forecast period. The report on the global microrna (mirna) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of cancer and the imperative for advanced diagnostics and therapeutics, technological advancements in mirna research tools, rising demand for non-invasive diagnostic methods.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 20.5% |
| CAGR | 22.3% |
| Incremental Value | $4211.4 mn |
Technavio's global microrna (mirna) market is segmented as below:
By Type
By End-User
By Application
Geography
This study identifies the integration into multi analyte liquid biopsies as one of the prime reasons driving the global microrna (mirna) market growth during the next few years. Also, growing focus on mirna as therapeutic targets and integration of artificial intelligence in mirna data analysis will lead to sizable demand in the market.
The report on the global microrna (mirna) market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global microrna (mirna) market vendors that include BioGenex Laboratories Inc., Bio Rad Laboratories Inc., BioVendor LM, GeneCopoeia Inc., Illumina Inc., Merck KGaA, Miltenyi Biotec BV and Co. KG, NanoString Technologies Inc., New England Biolabs Inc., OriGene Technologies Inc., PerkinElmer US LLC, QIAGEN N.V., Quantabio, Regulus Therapeutics Inc., SeqMatic LLC, Takara Bio Inc., TAmiRNA GmbH, Thermo Fisher Scientific Inc.. Also, the global microrna (mirna) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.